Dow Up 0.11% Nasdaq Up 0.50%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
18.19 Up 0.38(2.13%) Aug 29, 4:00PM EDT
|After Hours : 18.26 Up 0.07 (0.38%) Aug 29, 7:51PM EDT
Prev Close:17.81
Open:17.95
Bid:18.26 x 100
Ask:18.30 x 200
1y Target Est:23.42
Beta:4.16
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:17.87 - 18.20
52wk Range:8.56 - 18.48
Volume:1,421,541
Avg Vol (3m):1,534,430
Market Cap:1.67B
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for KERX

Comparison

Symbol% ChgMkt Cap
KERXUp 2.13%1.67B
BAXUp 0.09%40.61B
SHPGDown 0.21%47.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):163.53
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.89
Quarterly EPS Est (Sep-14) :-0.27
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.67

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback